暂时性缺血病发作的发生率和与中风的长期风险的关联
Vasileios-Arsenios Lioutas1,2, Cristina S Ivan3, Jayandra J Himali2,4,5,6,7
1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
JAMA
|January 26, 2021
概括
过渡性缺血性攻击 (TIA) 显著增加了中风的风险,风险增加了4. 37倍. 然而,TIA后90天的中风风险随着时间的推移而下降,近年来出现了显著的改善.
科学领域:
- 神经学
- 流行病学
- 公共卫生
背景情况:
- 对于有效的预防策略来说,精确估计中风风险是非常重要的.
- 了解TIA中风风险的时间趋势可以为公共卫生干预和资源分配提供信息.
研究的目的:
- 为了确定基于人口的TIA发病率.
- 分析TIA中风风险的时间和长期趋势.
- 将TIA患者的中风风险与对照组进行比较.
主要方法:
- 使用前性收集的Framingham心脏研究 (1948-2017) 数据进行的回顾性队列研究.
- 包括14059名没有TIA或中风病史的参与者,与没有TIA的对照组匹配TIA病例 (5:1比率).
- 对TIA发病率,短期和长期中风比例以及90天中风风险的时间趋势进行分析.
主要成果:
- 转移性心脏病发病率是每1000人/年中的1. 19.
- 与对照组相比,TIA患者的10年中风风险显著高 (0. 46),风险比为4. 37.
- 经过TIA的90天中风风险从1948年至1985年的16. 7%显著下降到2000年至2017年的5. 9%.
结论:
- 这种TIA与随后中风的风险大大增加有关.
- 近几十年来,TIA导致的中风风险呈显著下降趋势.
- 这些发现突显了随着时间的推移,TIA管理和中风预防的改善.
相关概念视频
Ischemic Heart Disease: Overview
2.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
219
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
219


